Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
Open accessThe DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Abstract
Recent decades have witnessed tremendous advances in the neuroscience of emotion, learning and memory, and in animal models for understanding depression and anxiety. This review focuses on new rationally designed psychiatric treatments derived from preclinical human and animal studies. Nonpharmacological treatments that affect disrupted emotion circuits include vagal nerve stimulation, rapid transcranial magnetic stimulation and deep brain stimulation, all borrowed from neurological interventions that attempt to target known pathological foci. Other approaches include drugs that are given in relation to specific learning events to enhance or disrupt endogenous emotional learning processes. Imaging data suggest that common regions of brain activation are targeted with pharmacological and somatic treatments as well as with the emotional learning in psychotherapy. Although many of these approaches are experimental, the rapidly developing understanding of emotional circuit regulation is likely to provide exciting and powerful future treatments for debilitating mood and anxiety disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“frequent comorbidity with anxiety (Gorman, 1996) and commonalities of symptomatology and treatment response indicate a strong case for considering the disorders together in a neurobiological context (Ressler and Mayberg, 2007).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Ressler and Mayberg, 2007
In the citing paper
“This model has subsequently been developed and shown to have value in both diagnosis and prediction of treatment response (Mayberg et al., 2002;2003;Ressler and Mayberg, 2007).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Ressler and Mayberg, 2007
In the citing paper
“nearby subgenual cingulate has become an important target for treatment of depression [87].”
From Distinct Brain Systems Mediate the Effects of Nociceptive Input and Self-Regulation on Pain (2015) · cites this paper as [87]
In the citing paper
“Both disorders were included due to high levels of comorbidity between the conditions (Brown et al., 2001; Kaufman and Charney, 2000), overlapping symptoms, both responding to similar therapies (Ressler and Mayberg, 2007), and the same theory being used to model therapeutic response across disorders (Messina et al., 2013).”
From Meta-analyses of the neural mechanisms and predictors of response to psychotherapy in depression and anxiety (2018) · cites this paper as Ressler and Mayberg, 2007
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
How do you feel? Interoception: The sense of the physiological condition of the body
Craig, A. D. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn894 · Cited by 6,006
NON-INVASIVE MAGNETIC STIMULATION OF HUMAN MOTOR CORTEX
Barker, A. T., Jalinous, R., & Freeston, I. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92413-4 · Cited by 4,460
Memory - A century of consolidation
McGaugh, J. L. (2000) · Science · doi:10.1126/science.287.5451.248 · Cited by 4,250
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
Self-citationFear memories require protein synthesis in the amygdala for reconsolidation after retrieval
Nader, K., Schafe, G. E., & Le Doux, J. E. (2000) · Nature · doi:10.1038/35021052 · Cited by 2,706
Mayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416
Self-citationEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S., Egan, M. F., Mattay, V. S., Hariri, A. R., & Weinberger, D. R. (2005) · Nature Neuroscience · doi:10.1038/nn1463 · Cited by 1,980
Cited by
Items 301–400 of 997
Kross, E. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04545.x · Cited by 68
Enhancement of Memories by Systemic Administration of Insulin-Like Growth Factor II
Stern, S. A., Kohtz, A. S., Pollonini, G., & Alberini, C. M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.69 · Cited by 70
Shared and distinct homotopic connectivity changes in melancholic and non-melancholic depression
Shan, X., Cui, X., Liu, F., Li, H., Huang, R., Tang, Y., Chen, J., Zhao, J., Guo, W., & Xie, G. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.03.038 · Cited by 74
Bukalo, O., Pinard, C. R., & Holmes, A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12779 · Cited by 67
A Review of the Conceptualisation and Risk Factors Associated with Treatment-Resistant Depression
Murphy, J. A., Sarris, J., & Byrne, G. J. (2017) · Depression Research and Treatment · doi:10.1155/2017/4176825 · Cited by 67
Zhou, H., Martinez, E., Lin, H. H., Yang, R., Dale, J., Liu, K., Huang, D., & Wang, J. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00240 · Cited by 72
Are there meaningful biomarkers of treatment response for depression?
Breitenstein, B., Scheuer, S., & Holsboer, F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.002 · Cited by 73
Phillips, C. (2017) · Neural Plasticity · doi:10.1155/2017/7014146 · Cited by 65
Chesnut, M., Harati, S., Paredes, P. E., Khan, Y., Foudeh, A. M., Kim, J., Bao, Z., & Williams, L. M. (2021) · Chronic Stress · doi:10.1177/24705470211000338 · Cited by 74
Kreuzer, P. M., Schecklmann, M., Lehner, A., Wetter, T. C., Poeppl, T. B., Rupprecht, R., de Ridder, D., Landgrebe, M., & Langguth, B. (2015) · Brain Stimulation · doi:10.1016/j.brs.2014.11.014 · Cited by 65
Modulation of Intrinsic Brain Activity by Electroconvulsive Therapy in Major Depression
Leaver, A. M., Espinoza, R., Pirnia, T., Joshi, S. H., Woods, R. P., & Narr, K. L. (2016) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.09.001 · Cited by 66
Khalid, A., Kim, B. S., Chung, M. K., Ye, J. C., & Jeon, D. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.07.040 · Cited by 73
Brain imaging correlates of cognitive impairment in depression
Thomas, E. J. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.030.2009 · Cited by 64
Lakhan, S. E., & Callaway, E. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-60 · Cited by 78
Molecular Tools and Approaches for Optogenetics
Yuan, M., & Zhang, F. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.019 · Cited by 78
Brain, networks, depression, and more
Leistedt, S., & Linkowski, P. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.10.011 · Cited by 69
Lesage, A., & Steckler, T. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.043 · Cited by 73
Merkl, A., Neumann, W.-J., Huebl, J., Aust, S., Horn, A., Krauss, J. K., Dziobek, I., Kuhn, J., Schneider, G.-H., Bajbouj, M., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhv100 · Cited by 63
Cash, R. F. H., Cocchi, L., Anderson, R., Rogachov, A., Kucyi, A., Barnett, A. J., Zalesky, A., & Fitzgerald, P. B. (2019) · Human Brain Mapping · doi:10.1002/hbm.24725 · Cited by 70
Chen, M.-H., Li, C.-T., Lin, W.-C., Hong, C.-J., Tu, P.-C., Bai, Y.-M., Cheng, C.-M., & Su, T.-P. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.008 · Cited by 63
Neuronal coding of implicit emotion categories in the subcallosal cortex in patients with depression
Laxton, A. W., Neimat, J. S., Davis, K. D., Womelsdorf, T., Hutchison, W. D., Dostrovsky, J. O., Hamani, C., Mayberg, H. S., & Lozano, A. M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.029 · Cited by 62
Self-citationSpontaneous Neural Dynamics and Multi-scale Network Organization
Foster, B. L., He, B. J., Honey, C. J., Jerbi, K., Maier, A., & Saalmann, Y. B. (2016) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2016.00007 · Cited by 73
From Engrams to Pathologies of the Brain
Denny, C. A., Lebois, E., & Ramirez, S. (2017) · Frontiers in Neural Circuits · doi:10.3389/fncir.2017.00023 · Cited by 61
Kozel, F. A., Rao, U., Lu, H., Nakonezny, P. A., Grannemann, B., McGregor, T., Croarkin, P. E., Mapes, K. S., Tamminga, C. A., & Trivedi, M. H. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00007 · Cited by 61
Henje Blom, E., Duncan, L. G., Ho, T. C., Connolly, C. G., LeWinn, K. Z., Chesney, M., Hecht, F. M., & Yang, T. T. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00630 · Cited by 61
Li, H., Xiao, Y., Han, L., Jia, Y., Luo, S., Zhang, D., Zhang, L., Wu, P., Xiao, C., Kan, W., et al. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.03.002 · Cited by 67
EEG Microstates in Mood and Anxiety Disorders: A Meta-analysis
Chivu, A. C., Pascal, S. A., Damborská, A., & Tomescu, M. I. (2023) · Brain Topography · doi:10.1007/s10548-023-00999-0 · Cited by 78
Chen, L., Hudaib, A., Hoy, K. E., & Fitzgerald, P. B. (2019) · Depression and Anxiety · doi:10.1002/da.22894 · Cited by 61
Optogenetics enlightens neuroscience drug discovery
Song, C., & Knöpfel, T. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.15 · Cited by 70
The future of functional MRI in clinical medicine
Bullmore, E. T. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.026 · Cited by 72
Toda, H., Boku, S., Nakagawa, S., Inoue, T., Kato, A., Takamura, N., Song, N., Nibuya, M., Koyama, T., & Kusumi, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097421 · Cited by 59
Raineki, C., Bodnar, T. S., Holman, P. J., Baglot, S. L., Lan, N., & Weinberg, J. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.07.001 · Cited by 71
Chen, B., Li, J., Xie, Y., Ming, X., Li, G., Wang, J., Li, M., Li, X., & Xiong, L. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112088 · Cited by 62
Attwells, S., Setiawan, E., Rusjan, P., Xu, C., Hutton, C., Rafiei, D., Varughese, B., Kahn, A., Kish, S. J., Vasdev, N., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.007 · Cited by 64
A bidirectional corticoamygdala circuit for the encoding and retrieval of detailed reward memories
Sias, A. C., Morse, A. K., Wang, S., Greenfield, V. Y., Goodpaster, C. M., Wrenn, T. M., Wikenheiser, A. M., Holley, S. M., Cepeda, C., Levine, M. S., et al. (2021) · eLife · doi:10.7554/elife.68617 · Cited by 59
Pharmacological Treatment of Obsessive-Compulsive Disorder
Simpson, H. B. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_12 · Cited by 59
Gut microbiome-brain-cirrhosis axis
Smith, M. L., Wade, J. B., Wolstenholme, J. T., & Bajaj, J. S. (2023) · Hepatology · doi:10.1097/hep.0000000000000344 · Cited by 68
The interplay between microbiota and brain-gut axis in epilepsy treatment
Zhu, H., Wang, W., & Li, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1276551 · Cited by 74
Cerebellar vermis volume in major depressive disorder
Yücel, K., Nazarov, A., Taylor, V. H., Macdonald, K., Hall, G. B., & MacQUEEN, G. M. (2012) · Brain Structure and Function · doi:10.1007/s00429-012-0433-2 · Cited by 66
Sacher, J., Houle, S., Parkes, J., Rusjan, P., Sagrati, S., Wilson, A. A., & Meyer, J. H. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100117 · Cited by 59
Olivier, J. D. A., Vinkers, C. H., & Olivier, B. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00074 · Cited by 58
Evidence for Impaired Neocortical Synaptic Plasticity in Bipolar II Disorder
Elvsåshagen, T., Moberget, T., Bøen, E., Boye, B., Englin, N. O. A., Pedersen, P. Ø., Andreassen, O. A., Dietrichs, E., Malt, U. F., & Andersson, S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.026 · Cited by 63
Garcia‐García, Á. L., Meng, Q., Canetta, S., Gardier, A. M., Guiard, B. P., Kellendonk, C., Dranovsky, A., & Leonardo, E. D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.021 · Cited by 67
The Role of Biomarkers in Psychiatry
Lozupone, M., Montagna, M. L., D’Urso, F., Daniele, A., Greco, A., Seripa, D., Logroscino, G., Bellomo, A., & Panza, F. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_7 · Cited by 67
Increased amygdala response to shame in remitted major depressive disorder
Pulcu, E., Lythe, K., Elliott, R., Green, S., Moll, J., Deakin, J. F. W., & Zahn, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086900 · Cited by 57
Fullana, N., Gasull-Camós, J., Tarrés-Gatius, M., Castañé, A., Bortolozzi, A., & Artigas, F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107914 · Cited by 57
Robinson, E. S. J. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0036 · Cited by 69
Hard to look on the bright side: Neural correlates of impaired emotion regulation in depressed youth
Stephanou, K., Davey, C. G., Kerestes, R., Whittle, S., & Harrison, B. J. (2017) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsx039 · Cited by 54
Krishnan, V., Graham, A., Mazei-Robison, M. S., Lagace, D. C., Kim, K.-S., Birnbaum, S., Eisch, A. J., Han, P.-L., Storm, D. R., Zachariou, V., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.026 · Cited by 56
Sevelinges, Y., Mouly, A.-M., Raineki, C., Moriceau, S., Forest, C., & Sullivan, R. M. (2011) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2010.07.005 · Cited by 56
Chen, Y., Chen, C., Martínez, R. M., Etnier, J. L., & Cheng, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-56226-z · Cited by 70
Deep brain stimulation for treatment-resistant depression.
Taghva, A. S., Malone, D. A., & Rezai, A. R. (2013) · World Neurosurgery · doi:10.1016/j.wneu.2012.10.068 · Cited by 56
Ravenelle, R., Santolucito, H. B., Byrnes, E. M., BYRNES, J. J., & Donaldson, S. T. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.060 · Cited by 66
Prinsloo, G. E., Derman, W. E., Lambert, M., & Rauch, L. (2013) · International Journal of Stress Management · doi:10.1037/a0034777 · Cited by 70
Increased Seasonal Variation in Serotonin Transporter Binding in Seasonal Affective Disorder
Tyrer, A. E., Levitan, R. D., Houle, S., Wilson, A. A., Nóbrega, J. N., & Meyer, J. H. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.54 · Cited by 61
The role of serotonin in depression—A historical roundup and future directions
Bremshey, S., Groß, J., Renken, K., & Masseck, O. A. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16097 · Cited by 69
Pharmacological enhancement of fear reduction: preclinical models
Graham, B. M., Langton, J. M., & Richardson, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01175.x · Cited by 55
Mechanisms of Action of TMS in the Treatment of Depression
Downar, J. H., Siddiqi, S., Mitra, A., Williams, N., & Liston, C. M. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_483 · Cited by 66
The Role of Stress and Fear in the Development of Mental Disorders
Gonzalez, P., & Martínez, K. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.08.010 · Cited by 62
Galatzer‐Levy, I. R., Andero, R., Sawamura, T., Jovanović, T., Papini, S., Ressler, K. J., & Norrholm, S. D. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.023 · Cited by 59
Self-citationNeurostimulatory and ablative treatment options in major depressive disorder: a systematic review
Andrade, P., Noblesse, L. H. M., Temel, Y., Ackermans, L., Lim, L. W., Steinbusch, H. W. M., & Visser-Vandewalle, V. (2010) · Acta Neurochirurgica · doi:10.1007/s00701-009-0589-6 · Cited by 53
Region-specific glutamate changes in patients with unipolar depression
Grimm, S., Luborzewski, A., Schubert, F., Merkl, A., Kronenberg, G., Colla, M., Heuser, I., & Bajbouj, M. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.04.018 · Cited by 52
“These regions differ functionally as well as in their responsiveness toward a specific antidepressant treatment (Ressler and Mayberg, 2007).”
BackgroundBlock, S. R., & Liberzon, I. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.009 · Cited by 52
Kaster, T. S., Downar, J. H., Vila‐Rodriguez, F., Baribeau, D. A., Thorpe, K. E., Daskalakis, Z. J., & Blumberger, D. M. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101765 · Cited by 58
Neural mechanisms of cognitive reappraisal in remitted major depressive disorder
Smoski, M. J., Keng, S.-L., Schiller, C. E., Minkel, J., & Dichter, G. S. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.073 · Cited by 52
Ihne, J. L., Fitzgerald, P. J., Hefner, K. R., & Holmes, A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.045 · Cited by 52
Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits
Soliman, A., Bagby, R. M., Wilson, A. A., Miler, L., Clark, M., Rusjan, P., Sacher, J., Houle, S., & Meyer, J. H. (2011) · Psychological Medicine · doi:10.1017/s0033291710001601 · Cited by 52
A Portable Ultrasound System for Non-Invasive Ultrasonic Neuro-Stimulation
Qiu, W., Zhou, J., Chen, Y., Su, M., Li, G., Zhao, H., Gu, X., Meng, D., Wang, C., Xiao, Y., et al. (2017) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2017.2765001 · Cited by 57
Increased subgenual prefrontal cortex size in remitted patients with major depressive disorder
Yücel, K., MKinnon, M., Chahal, R., Taylor, V. H., Macdonald, K., Joffe, R. T., & MacQUEEN, G. M. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.07.013 · Cited by 56
Propofol-induced deep sedation reduces emotional episodic memory reconsolidation in humans
Galarza-Vallejo, A., Kroes, M. C. W., Rey, E., Acedo, M. V., Moratti, S., Fernández, G., & Strange, B. A. (2019) · Science Advances · doi:10.1126/sciadv.aav3801 · Cited by 56
Smoski, M. J., Keng, S.-L., Ji, J. L., Moore, T., Minkel, J., & Dichter, G. S. (2015) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsv003 · Cited by 51
“Emotion regulation is especially critical in the context of major depressive disorder (MDD), in which biological, cognitive and behavioral responses to affective stimuli are dysregulated (Davidson et al. , 2002; Ressler and Mayberg, 2007).”
BackgroundVergallito, A., Gallucci, A., Pisoni, A., Punzi, M., Caselli, G., Ruggiero, G. M., Sassaroli, S., & Lauro, L. J. R. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.210050 · Cited by 66
Aversive memory formation in humans involves an amygdala-hippocampus phase code
Costa, M., Lozano‐Soldevilla, D., Gil‐Nagel, A., Toledano, R., Oehrn, C. R., Kunz, L., Yebra, M., Méndez‐Bértolo, C., Stieglitz, L. H., Sarnthein, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33828-2 · Cited by 56
MR-Guided Transcranial Focused Ultrasound
Aubry, J., & Tanter, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22536-4_6 · Cited by 57
Clinical Applications and Future Directions of Functional MRI
Orringer, D. A., Vago, D. R., & Golby, A. J. (2013) · Seminars in Neurology · doi:10.1055/s-0032-1331816 · Cited by 66
Persistent pain alters AMPA receptor subunit levels in the nucleus accumbens
Su, C. H., D’amour, J. A., Lee, M. S., Lin, H.-Y., Manders, T. R., Xu, D., Eberle, S. E., Goffer, Y., Zou, A., Rahman, M., et al. (2015) · Molecular Brain · doi:10.1186/s13041-015-0140-z · Cited by 55
maLPA1-null mice as an endophenotype of anxious depression
Moreno‐Fernández, R. D., Pérez‐Martín, M., Castilla‐Ortega, E., Rosell‐Valle, C., Garcia‐Fernandez, M. I., Chun, J. J. M., Estivill‐Torrús, G., de Fonseca, F. R., Santín, L. J., & Pedraza, C. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.24 · Cited by 49
Cellular, circuit and transcriptional framework for modulation of itch in the central amygdala
Samineni, V. K., Grajales‐Reyes, J. G., Grajales‐Reyes, G. E., Tycksen, E., Copits, B. A., Pedersen, C. E., Ankudey, E. S., Sackey, J. N., Sewell, S. B., Bruchas, M. R., et al. (2021) · eLife · doi:10.7554/elife.68130 · Cited by 54
The dose makes the poison: From glutamate-mediated neurogenesis to neuronal atrophy and depression
Rubio-Casillas, A., & Fernández-Guasti, A. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0066 · Cited by 49
“Postmortem studies report fewer GABA neurons in patients with major depression disorder (MDD) or bipolar disorder.”
BackgroundInfluentialSerotonergic Modulation of Conditioned Fear
Homberg, J. R. (2012) · Scientifica · doi:10.6064/2012/821549 · Cited by 58
Matsuoka, Y., Nishi, D., Noguchi, H., Kim, Y., & Hashimoto, K. (2013) · Neuropsychobiology · doi:10.1159/000350950 · Cited by 49
Kreuzer, P. M., Lehner, A., Schlee, W., Vielsmeier, V., Schecklmann, M., Poeppl, T. B., Landgrebe, M., Rupprecht, R., & Langguth, B. (2015) · Scientific Reports · doi:10.1038/srep18028 · Cited by 49
Desynchronization and Plasticity of Striato-frontal Connectivity in Major Depressive Disorder
Leaver, A. M., Espinoza, R., Joshi, S. H., Vasavada, M., Njau, S., Woods, R. P., & Narr, K. L. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhv207 · Cited by 48
Seeking an Objective Diagnosis of Depression
Bilello, J. A. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0076 · Cited by 48
Vagus nerve stimulation as a tool for enhancing extinction in exposure-based therapies
Noble, L. J., de Souza, R. R., & McIntyre, C. K. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4994-5 · Cited by 53
Reduced medial prefrontal responses to social interaction images in remitted depression
Elliott, R. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.139 · Cited by 47
Gebhardt, N., Bär, K.-J., Boettger, M. K., Grecksch, G., Keilhoff, G., Reichart, R., & Becker, A. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.01.009 · Cited by 48
Green, S., Lambon Ralph, M. A., Moll, J., Stamatakis, E. A., Grafman, J., & Zahn, R. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.05.038 · Cited by 48
Matsuoka, Y., Nishi, D., Hamazaki, K., Yonemoto, N., Matsumura, K., Noguchi, H., Hashimoto, K., & Hamazaki, T. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09260 · Cited by 52
Kolla, N. J., Chiuccariello, L., Wilson, A. A., Houle, S., Links, P. S., Bagby, R. M., McMain, S., Kellow, C., Patel, J., Rekkas, P. V., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.024 · Cited by 49
Paes, F., Machado, S., Arias-Carrion, O., Velasques, B., Teixeira, S., Budde, H., Cagy, M., Piedade, R., Ribeiro, P., P. Huston, J., et al. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711796234943 · Cited by 47
Cacciaglia, R., Nees, F., Grimm, O., Ridder, S., Pohlack, S. T., Diener, S. J., Liebscher, C., & Flor, H. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.012 · Cited by 52
The role of neurotrophic factors in novel, rapid psychiatric treatments
Kim, J., He, M. J., Widmann, A. K., & Lee, F. S. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01717-x · Cited by 51
The Emerging Use of Technology for the Treatment of Depression and Other Neuropsychiatric Disorders
Howland, R. H., Shutt, L. S., Berman, S. R., Spotts, C. R., & Denko, T. (2011) · Annals of Clinical Psychiatry · doi:10.1177/104012371102300108 · Cited by 46
Woltering, S., Liao, V., Liu, Z., & Granic, I. (2015) · Neural Plasticity · doi:10.1155/2015/873197 · Cited by 51
Savalli, G., Diao, W., Berger, S., Ronovsky, M., Partonen, T., & Pollak, D. D. (2015) · Amino Acids · doi:10.1007/s00726-015-1968-3 · Cited by 46
Nishi, D., Koido, Y., Nakaya, N., Sone, T., Noguchi, H., Hamazaki, K., Hamazaki, T., & Matsuoka, Y. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000336811 · Cited by 46
Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei
Vázquez-Borsetti, P., Celada, P., Cortés, R., & Artigas, F. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000349 · Cited by 46
Kito, S., Hasegawa, T., Takamiya, A., Noda, T., Nakagome, K., Higuchi, T., & Koga, Y. (2017) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.15120419 · Cited by 46
Phf8 loss confers resistance to depression-like and anxiety-like behaviors in mice
Walsh, R. M., Shen, E., Bagot, R. C., Anselmo, A. N., Jiang, Y., Javidfar, B., Wojtkiewicz, G. R., Cloutier, J. K., Chen, J. W., Sadreyev, R. I., et al. (2017) · Nature Communications · doi:10.1038/ncomms15142 · Cited by 47
Metadata
- Authors
- Ressler, K. J., & Mayberg, H. S.
- Affiliations
- Emory University (US)
- Corresponding author
- Ressler, Kerry J
- Venue
- Nature Neuroscience
- Published
- 2007-08-28
- Volume
- 10
- Issue
- 9
- Pages
- 1116-1124
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC2444035
- OpenAlex
- W2100991928
- Cited by
- 1,007
- References
- 104
- Citations by year
- 2026: 28 · 2025: 45 · 2024: 44 · 2023: 44 · 2022: 32 · 2021: 57 · 2020: 41 · 2019: 54 · 2018: 51 · 2017: 59 · 2016: 54 · 2015: 74 · 2014: 53 · 2013: 84 · 2012: 63
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (P50MH058922, MH 071537, R01MH073719, MH069884, R01MH071537, P50MH077083, R56MH071537, K01MH069884, P50 MH58922)
- National Institute on Drug Abuse (R01DA019624, DA-019624)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Keywords
- mood disorders, anxiety disorders, depression, neural circuits, emotion regulation, vagus nerve stimulation, deep brain stimulation, emotional learning, psychotherapy, neuroimaging, neuromodulation
- MeSH terms
- Affect, Animals, Anxiety Disorders, Brain Mapping, Electroconvulsive Therapy, Humans, Laboratories, Models, Psychological, Nerve Net, Mood Disorders, Deep Brain Stimulation, Transcranial Magnetic Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.